Ocugen Inc
OCGN1.000USD
+0.006+0.64%
Cierre 08/04, 16:00（ET）Cotizaciones retrasadas 15 min
292.03MCap. mercado
PérdidaP/E TTM
Más Datos de Ocugen Inc Compañía
Ocugen, Inc. is a biopharmaceutical company. The Company is focused on discovering, developing, and commercializing gene and cell therapies, biologics, and vaccines that improve health for patients across the globe. Its technology pipeline includes modifier gene therapy platform, regenerative medicine cell therapy platform, and biologic therapies for retinal diseases. The Company is developing its modifier gene therapy platform, inclusive of OCU400, OCU410, and OCU410ST, for the treatment of multiple inherited retinal disease (IRDs), including retinitis pigmentosa (RP), Leber congenital amaurosis (LCA), Stargardt disease and multifactorial diseases such as dry age-related macular degeneration (dAMD) and geographic atrophy (GA). It is developing an inhalation-based mucosal vaccine platform based on a novel ChAd vector, which includes OCU500, a COVID-19 vaccine; OCU510, a seasonal quadrivalent flu vaccine; and OCU520, a combination quadrivalent seasonal flu and COVID-19 vaccine.
Información de la empresa
Símbolo de cotizaciónOCGN
Nombre de la empresaOcugen Inc
Fecha de salida a bolsaDec 03, 2014
Director ejecutivoDr. Shankar Musunuri, Ph.D.
Número de empleados95
Tipo de seguridadOrdinary Share
Fin del año fiscalDec 03
Dirección11 Great Valley Parkway
CiudadMALVERN
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal19355
Teléfono14843284701
Sitio Webhttps://ocugen.com/
Símbolo de cotizaciónOCGN
Fecha de salida a bolsaDec 03, 2014
Director ejecutivoDr. Shankar Musunuri, Ph.D.
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Junge Zhang, Ph.D.
Mr. Junge Zhang, Ph.D.
Independent Director
Independent Director
1.17M
+0.01%
Dr. Arun Upadhyay, Ph.D.
Dr. Arun Upadhyay, Ph.D.
Chief Scientific Officer, Head of Research and Development
Chief Scientific Officer, Head of Research and Development
214.50K
+250.87%
Ms. Kirsten Castillo
Ms. Kirsten Castillo
Independent Director
Independent Director
75.00K
+50.00%
Mr. Ramesh Ramachandran, CPA
Mr. Ramesh Ramachandran, CPA
Chief Accounting Officer
Chief Accounting Officer
1.80K
--
Ms. Tiffany Hamilton
Ms. Tiffany Hamilton
Head of Communications
Head of Communications
--
--
Dr. Shankar Musunuri, Ph.D.
Dr. Shankar Musunuri, Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Dr. Huma Qamar, M.D.
Dr. Huma Qamar, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Uday B. Kompella, Ph.D.
Dr. Uday B. Kompella, Ph.D.
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Junge Zhang, Ph.D.
Mr. Junge Zhang, Ph.D.
Independent Director
Independent Director
1.17M
+0.01%
Dr. Arun Upadhyay, Ph.D.
Dr. Arun Upadhyay, Ph.D.
Chief Scientific Officer, Head of Research and Development
Chief Scientific Officer, Head of Research and Development
214.50K
+250.87%
Ms. Kirsten Castillo
Ms. Kirsten Castillo
Independent Director
Independent Director
75.00K
+50.00%
Mr. Ramesh Ramachandran, CPA
Mr. Ramesh Ramachandran, CPA
Chief Accounting Officer
Chief Accounting Officer
1.80K
--
Ms. Tiffany Hamilton
Ms. Tiffany Hamilton
Head of Communications
Head of Communications
--
--
Dr. Shankar Musunuri, Ph.D.
Dr. Shankar Musunuri, Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Desglose de ingresos
FY2025Q1
FY2024
FY2023
FY2021
FY2020
Sin datos
Por regiónUSD
Nombre
Ganancia
Proporción
United States
1.48M
0.00%
Por negocio
Por región
Sin datos
Estadísticas de accionistas
Actualizado: sáb., 17 de may
Actualizado: sáb., 17 de may
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
6.24%
The Vanguard Group, Inc.
5.71%
Geode Capital Management, L.L.C.
2.36%
State Street Global Advisors (US)
2.03%
GMT Capital Corp.
1.42%
Other
82.24%
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
6.24%
The Vanguard Group, Inc.
5.71%
Geode Capital Management, L.L.C.
2.36%
State Street Global Advisors (US)
2.03%
GMT Capital Corp.
1.42%
Other
82.24%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
15.79%
Investment Advisor/Hedge Fund
6.52%
Hedge Fund
3.35%
Individual Investor
1.21%
Research Firm
0.74%
Corporation
0.39%
Bank and Trust
0.17%
Pension Fund
0.02%
Other
71.80%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
267
82.38M
28.21%
-9.38M
2025Q1
278
81.07M
27.89%
-11.63M
2024Q4
292
76.62M
26.34%
-21.25M
2024Q3
306
84.66M
29.43%
-6.14M
2024Q2
300
72.04M
27.84%
+19.28M
2024Q1
302
36.88M
14.47%
-15.26M
2023Q4
300
30.54M
12.06%
-31.79M
2023Q3
314
37.28M
14.69%
-34.75M
2023Q2
332
53.23M
20.91%
-28.29M
2023Q1
336
68.93M
30.49%
-36.35M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
BlackRock Institutional Trust Company, N.A.
18.22M
6.24%
-377.91K
-2.03%
Mar 31, 2025
The Vanguard Group, Inc.
16.68M
5.71%
+64.02K
+0.39%
Mar 31, 2025
Geode Capital Management, L.L.C.
6.89M
2.36%
+300.41K
+4.56%
Mar 31, 2025
State Street Global Advisors (US)
5.93M
2.03%
+65.93K
+1.12%
Mar 31, 2025
GMT Capital Corp.
4.15M
1.42%
+1.70M
+69.20%
Mar 31, 2025
UBS Financial Services, Inc.
4.15M
1.42%
+3.42M
+469.31%
Mar 31, 2025
Renaissance Technologies LLC
3.46M
1.18%
+1.37M
+65.70%
Mar 31, 2025
Northern Trust Investments, Inc.
2.30M
0.79%
-103.69K
-4.31%
Mar 31, 2025
GSA Capital Partners LLP
1.64M
0.56%
+492.30K
+42.97%
Mar 31, 2025
Musunuri (Shankar Ph.D)
1.34M
0.46%
+607.32K
+82.50%
Apr 14, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 2 de ago
Actualizado: sáb., 2 de ago
Nombre
Proporción
Invesco NASDAQ Future Gen 200 ETF
0.52%
iShares Micro-Cap ETF
0.01%
Pacer WealthShield ETF
0%
iShares Russell 2000 ETF
0%
ProShares UltraPro Russell2000
0%
ProShares Hedge Replication ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Russell 2000 Growth ETF
0%
Global X Russell 2000 ETF
0%
Proshares Ultra Russell 2000
0%
Ver más
Invesco NASDAQ Future Gen 200 ETF
Proporción0.52%
iShares Micro-Cap ETF
Proporción0.01%
Pacer WealthShield ETF
Proporción0%
iShares Russell 2000 ETF
Proporción0%
ProShares UltraPro Russell2000
Proporción0%
ProShares Hedge Replication ETF
Proporción0%
iShares Core S&P Total U.S. Stock Market ETF
Proporción0%
iShares Russell 2000 Growth ETF
Proporción0%
Global X Russell 2000 ETF
Proporción0%
Proshares Ultra Russell 2000
Proporción0%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
